|
1
|
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
|
Proc Natl Acad Sci U S A
|
2002
|
1.88
|
|
2
|
Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.
|
Circ Res
|
2003
|
1.82
|
|
3
|
Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy.
|
Circulation
|
2003
|
1.60
|
|
4
|
Active Rho kinase (ROK-alpha ) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells.
|
J Biol Chem
|
2001
|
1.58
|
|
5
|
Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins.
|
Neuron
|
2005
|
1.54
|
|
6
|
Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.
|
Cardiovasc Res
|
2003
|
1.51
|
|
7
|
Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.
|
J Biol Chem
|
2010
|
1.47
|
|
8
|
Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [corrected].
|
Circulation
|
2003
|
1.45
|
|
9
|
Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte.
|
J Biol Chem
|
2006
|
1.33
|
|
10
|
cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein.
|
J Biol Chem
|
2005
|
1.29
|
|
11
|
cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes.
|
J Biol Chem
|
2006
|
1.26
|
|
12
|
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
|
Hypertension
|
2002
|
1.16
|
|
13
|
Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs.
|
Am J Physiol Cell Physiol
|
2002
|
1.07
|
|
14
|
Cyclic guanosine 5'-monophosphate-dependent protein kinase II is induced by luteinizing hormone and progesterone receptor-dependent mechanisms in granulosa cells and cumulus oocyte complexes of ovulating follicles.
|
Mol Endocrinol
|
2005
|
0.93
|
|
15
|
Analysis of Drosophila cGMP-dependent protein kinases and assessment of their in vivo roles by targeted expression in a renal transporting epithelium.
|
J Biol Chem
|
2004
|
0.92
|
|
16
|
Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
|
Cardiovasc Res
|
2002
|
0.91
|
|
17
|
Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
|
Cardiovasc Res
|
2004
|
0.90
|
|
18
|
MKP-1 expression and stabilization and cGK Ialpha prevent diabetes- associated abnormalities in VSMC migration.
|
Am J Physiol Cell Physiol
|
2004
|
0.89
|
|
19
|
Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
|
Br J Pharmacol
|
2003
|
0.86
|
|
20
|
Quantitative analysis of the cardiac fibroblast transcriptome-implications for NO/cGMP signaling.
|
Genomics
|
2004
|
0.86
|
|
21
|
Inhibition of cGMP-dependent protein kinase II by its own splice isoform.
|
Biochem Biophys Res Commun
|
2002
|
0.78
|